Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in China with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Unknown status Country / region: China Clear all

454 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20064
200713
20084
20094
20109
201112
20129
201315
201415
201521
201624
201727
201831
201960
202049
202151
202248
202338
202414

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status454

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University75
Shanghai Zhongshan Hospital32
Fudan University26
Guangxi Medical University14
Peking Union Medical College Hospital13
Eastern Hepatobiliary Surgery Hospital12
Second Affiliated Hospital, Zhejiang University, School of Medicine11
Southwest Hospital, China9
Tianjin Medical University Cancer Institute and Hospital9
Zhongda Hospital9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular454
Liver Neoplasms27
Recurrence21
Stomach Neoplasms11
Colorectal Neoplasms9
Hepatitis B8
Hepatitis B, Chronic6
Pancreatic Neoplasms6
Cholangiocarcinoma5
Esophageal Neoplasms5

Trials

Showing 1 to 25 of 454. Each trial links to its page on Pharma Observatory.

354 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.